* DNA THERAPEUTICS *
2006 - IDF
Évry
(near Paris)
www.dna-therapeutics.com Discovery, Drugs
Key words: Cancer, siDNA, DNA repair
Mission: to develop proprietary siDNA (signal interfering DNA) technology platform and molecules, interfering with DNA damage repair mechanisms, to fight treatment-resistant cancers
Clients: Prescribers
contact@dna-therapeutics.com
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Personal venture |
Managing Dir.: Sun (Jian Sheg) [born 1959, Ph.D.]
Sc.Dir.: Sun (Jian Sheg)
Fin.Dir.:
BusDev:
Financers: privately owned | Turnover (M€) : n.a.
Total funding (M€) : 1.2
Last funding (M€) : 0.8
Focus : Cancers
Position : Preclin
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2008 .09 | Seed financing : 0.8 M€, led by Inserm Transfer Initiative, with G1J-Île de France, Blue Medical Investment Group and International Business Angels (parallely to a patent granted on SiDNA) | SFIN | [2 years] |
| 2006 .05 | Company founded by Prof. Jian Sheg Sun, from concepts elaborated by Jean-Marc Cosset and Marie Dutreix, in 2001 | ORGF | [0 year] | Actualisation / Updating: 31-Oct-2008 |
|
